Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
Yadav U, Kumar SK, Baughn LB, Dispenzieri A, Greipp P, Ketterling R, Jevremovic D, Buadi FK, Dingli D, Lacy MQ, Fonseca R, Bergsagel PL, Ailawadhi S, Roy V, Parrondo R, Sher T, Hayman SR, Kapoor P, Leung N, Cook J, Binder M, Muchtar E, Warsame R, Kourelis TV, Go RS, Lin Y, Seth A, Lester SC, Breen WG, Kyle RA, Gertz MA, Rajkumar SV, Gonsalves WI. Yadav U, et al. Among authors: lester sc. Blood. 2023 Nov 30;142(22):1871-1878. doi: 10.1182/blood.2023021187. Blood. 2023. PMID: 37494698 Free PMC article.
Comparable Efficacy of Reduced Dose Radiation Therapy for the Treatment of Early Stage Gastric Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue.
Saifi O, Lester SC, Rule W, Stish BJ, Stafford S, Pafundi DH, Jiang L, Menke D, Moustafa MA, Rosenthal A, Sher T, Ernesto A, Tun HW, Hoppe BS, Peterson JL. Saifi O, et al. Among authors: lester sc. Adv Radiat Oncol. 2021 May 8;6(4):100714. doi: 10.1016/j.adro.2021.100714. eCollection 2021 Jul-Aug. Adv Radiat Oncol. 2021. PMID: 34409210 Free PMC article.
Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?
Saifi O, Breen WG, Lester SC, Rule WG, Stish B, Rosenthal A, Munoz J, Herchko SM, Murthy HS, Lin Y, Bansal R, Hathcock MA, Bennani NN, Paludo J, Wang Y, Khurana A, Bisneto JCV, Johnston PB, Ansell SM, Iqbal M, Tun H, Ayala E, Kharfan-Dabaja MA, Hoppe BS, Peterson JL. Saifi O, et al. Among authors: lester sc. Radiother Oncol. 2022 Jan;166:171-179. doi: 10.1016/j.radonc.2021.11.031. Epub 2021 Dec 7. Radiother Oncol. 2022. PMID: 34890736 Free article.
Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT.
Breen WG, Hathcock MA, Young JR, Kowalchuk RO, Bansal R, Khurana A, Bennani NN, Paludo J, Villasboas Bisneto JC, Wang Y, Ansell SM, Peterson JL, Johnston PB, Lester SC, Lin Y. Breen WG, et al. Among authors: lester sc. J Hematol Oncol. 2022 Mar 26;15(1):36. doi: 10.1186/s13045-022-01256-w. J Hematol Oncol. 2022. PMID: 35346315 Free PMC article.
Outcomes of patients with stage I-II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy.
Frechette KM, Lester SC, Taparra K, Breen WG, Martenson JA, Hoppe BS, Peterson JL, Rule WG, Stafford SL, Stish BJ, Habermann TM, Young JR, Harmsen WS, Laack NN. Frechette KM, et al. Among authors: lester sc. Blood Cancer J. 2022 Aug 22;12(8):121. doi: 10.1038/s41408-022-00711-8. Blood Cancer J. 2022. PMID: 35995767 Free PMC article. No abstract available.
Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma.
Saifi O, Breen WG, Lester SC, Rule WG, Stish BJ, Rosenthal A, Munoz J, Lin Y, Bansal R, Hathcock MA, Bennani NN, Paludo J, Khurana A, Villasboas JC, Johnston PB, Ansell SM, Iqbal M, Moustafa MA, Murthy HS, Kharfan-Dabaja MA, Hoppe BS, Peterson JL. Saifi O, et al. Among authors: lester sc. Int J Radiat Oncol Biol Phys. 2023 Aug 1;116(5):999-1007. doi: 10.1016/j.ijrobp.2022.12.017. Epub 2022 Dec 21. Int J Radiat Oncol Biol Phys. 2023. PMID: 36563910
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma.
Saifi O, Breen WG, Lester SC, Rule WG, Stish BJ, Rosenthal A, Munoz J, Lin Y, Bansal R, Hathcock MA, Johnston PB, Ansell SM, Paludo J, Khurana A, Villasboas JC, Wang Y, Iqbal M, Moustafa MA, Murthy HS, Kharfan-Dabaja MA, Peterson JL, Hoppe BS. Saifi O, et al. Among authors: lester sc. Haematologica. 2023 Nov 1;108(11):2982-2992. doi: 10.3324/haematol.2023.283311. Haematologica. 2023. PMID: 37317888 Free PMC article.
Development and Dosimetric Characterization of a Customizable Shield for Subtotal Skin Electron Beam Therapy.
Lucido JJ, Penoncello GP, Laughlin BS, Armstrong MD, Lo SG, Rivera JN, Tang X, Chungbin SJ, Breen WG, Mangold AR, Comfere NI, Lester SC, Rule WG, Deufel CL, Foster MG. Lucido JJ, et al. Among authors: lester sc. Adv Radiat Oncol. 2023 Jun 14;8(6):101289. doi: 10.1016/j.adro.2023.101289. eCollection 2023 Nov-Dec. Adv Radiat Oncol. 2023. PMID: 37457824 Free PMC article.
Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity.
Breen WG, Young JR, Hathcock MA, Kowalchuk RO, Thorpe MP, Bansal R, Khurana A, Bennani NN, Paludo J, Bisneto JV, Wang Y, Ansell SM, Peterson JL, Johnston PB, Lester SC, Lin Y. Breen WG, et al. Among authors: lester sc. Blood Cancer J. 2023 Aug 18;13(1):127. doi: 10.1038/s41408-023-00895-7. Blood Cancer J. 2023. PMID: 37591834 Free PMC article.
134 results